Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Drago, L.
Mombelli, B.
Ciardo, G.
Vecchi, E. De
and
Gismondo, M.R.
1999.
Effects of Three Different Fish Oil7 Formulations onHelicobacter pyloriGrowth and Viability:In VitroStudy.
Journal of Chemotherapy,
Vol. 11,
Issue. 3,
p.
207.
Misciagna, G.
Cisternino, A.M.
and
Freudenheim, J.
2000.
Diet and duodenal ulcer.
Digestive and Liver Disease,
Vol. 32,
Issue. 6,
p.
468.
Pagkalos, Vasileios A
Moschandreas, Joanna
Kiriakakis, Michael
Roussomoustakaki, Maria
Kafatos, Anthony
and
Kouroumalis, Elias
2009.
Fatty acid composition of subcutaneous adipose tissue and gastric mucosa: is there a relation with gastric ulceration?.
BMC Gastroenterology,
Vol. 9,
Issue. 1,
Correia, Marta
Michel, Valérie
Matos, António A.
Carvalho, Patrícia
Oliveira, Maria J.
Ferreira, Rui M.
Dillies, Marie-Agnès
Huerre, Michel
Seruca, Raquel
Figueiredo, Ceu
Machado, Jose C.
Touati, Eliette
and
Adler, Ben
2012.
Docosahexaenoic Acid Inhibits Helicobacter pylori Growth In Vitro and Mice Gastric Mucosa Colonization.
PLoS ONE,
Vol. 7,
Issue. 4,
p.
e35072.
Lee, Sun Eun
Lim, Joo Weon
Kim, Jung Mogg
and
Kim, Hyeyoung
2014.
Anti-Inflammatory Mechanism of Polyunsaturated Fatty Acids inHelicobacter pylori-Infected Gastric Epithelial Cells.
Mediators of Inflammation,
Vol. 2014,
Issue. ,
p.
1.
Testerman, Traci L.
McGee, David J.
and
Mobley, Harry L. T.
2014.
Helicobacter pylori.
p.
379.
Jung, Sung Woo
Thamphiwatana, Soracha
Zhang, Liangfang
Obonyo, Marygorret
and
Saraiva, Ligia M
2015.
Mechanism of Antibacterial Activity of Liposomal Linolenic Acid against Helicobacter pylori.
PLOS ONE,
Vol. 10,
Issue. 3,
p.
e0116519.
Jung, Sung Woo
and
Lee, Sang Woo
2015.
The antibacterial effect of fatty acids on <i>Helicobacter pylori</i> infection.
The Korean Journal of Internal Medicine,
Vol. 31,
Issue. 1,
p.
30.
Park, Jong-Min
Jeong, Migyeong
Kim, Eun-Hee
Han, Young-Min
Kwon, Sung Hun
and
Hahm, Ki-Baik
2015.
Omega-3 Polyunsaturated Fatty Acids Intake to RegulateHelicobacter pylori-Associated Gastric Diseases as Nonantimicrobial Dietary Approach.
BioMed Research International,
Vol. 2015,
Issue. ,
p.
1.
Fahey, Jed W.
Stephenson, Katherine K.
and
Wallace, Alison J.
2015.
Dietary amelioration of Helicobacter infection.
Nutrition Research,
Vol. 35,
Issue. 6,
p.
461.
Venegas, Alejandro
Hantar Touma, Jorge
Bravo, Jessica
and
Perez-Perez, Guillermo
2016.
Progress in Use of Natural Products and Their Active Components against <i>Helicobacter pylori</i>.
Advances in Microbiology,
Vol. 06,
Issue. 14,
p.
1091.
Jackman, Joshua
Yoon, Bo
Li, Danlin
and
Cho, Nam-Joon
2016.
Nanotechnology Formulations for Antibacterial Free Fatty Acids and Monoglycerides.
Molecules,
Vol. 21,
Issue. 3,
p.
305.
Tran, Le Tuyet Chau
Gueutin, Claire
Frebourg, Ghislaine
Burucoa, Christophe
and
Faivre, Vincent
2017.
Erythromycin encapsulation in nanoemulsion-based delivery systems for treatment of Helicobacter pylori infection: Protection and synergy.
Biochemical and Biophysical Research Communications,
Vol. 493,
Issue. 1,
p.
146.
Sharifi, Rasoul
Nouri, Mohammad
Eidi, Akram
Noormohammadi, Zahra
Dolatkhah, Homayun
and
Shirmohammadi, Masoud
2017.
Dietary PUFA Increase Apoptosis in Stomach of Patients with Dyspeptic Symptoms and Infected with H. pylori.
Lipids,
Vol. 52,
Issue. 6,
p.
549.
Abdi, Saeed
Ataei, Sara
Abroon, Maede
Majma Sanaye, Pantea
Abbasinazari, Mohammad
and
Farrokhian, Amir
2022.
A Comprehensive Review of the Role of Complementary and Dietary Medicines in Eradicating Helicobacter pylori.
Iranian Journal of Pharmaceutical Research,
Vol. 21,
Issue. 1,
Dai, Zebin
Wang, Qinjian
He, Bingbing
Shi, Fang
Chen, Wei
Jiang, Qingxi
Zhou, Dan
Xue, Zhanxiong
and
Yang, Bo
2024.
Causal association of plasma n-3 PUFA with peptic ulcer disease: a two-sample Mendelian randomisation study.
British Journal of Nutrition,
Vol. 132,
Issue. 8,
p.
1014.